Highnoon Laboratories Income Statement

Financials in millions PKR. Fiscal year is January - December.

Millions PKR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	26,609	24,630	19,766	15,816	13,001	10,698
Revenue Growth (YoY)	15.58%	24.60%	24.98%	21.65%	21.53%	18.24%
Cost of Revenue	12,058	12,112	10,368	7,625	6,475	5,455
Gross Profit	14,551	12,518	9,398	8,190	6,526	5,243
Selling, General & Admin	8,308	6,977	5,720	4,649	3,985	3,122
Research & Development	9.47	9.47	15.02	10.63	8.67	6.38
Other Operating Expenses	445.85	533.91	-46.41	321.04	219.11	177.04
Operating Expenses	8,763	7,521	5,688	4,981	4,213	3,306
Operating Income	5,787	4,997	3,710	3,209	2,313	1,937
Interest Expense	-388.59	-395.03	-149.21	-57.07	-27.44	-25.73
Interest & Investment Income	-	151.36	99.43	233.75	132.59	60.74
Currency Exchange Gain (Loss)	-4.33	-	-335.58	-7.15	2.52	-8.36
Other Non Operating Income (Expenses)	2.06	12.94	45.33	38.79	-2.42	-1.57
EBT Excluding Unusual Items	5,397	4,766	3,370	3,418	2,418	1,962
Gain (Loss) on Sale of Investments	446.63	238.32	-24.44	9.25	10.59	4.87
Gain (Loss) on Sale of Assets	47.24	27.9	13.82	18.17	6.75	32.07
Pretax Income	5,890	5,032	3,359	3,445	2,436	1,999
Income Tax Expense	2,217	1,644	911.61	972.46	579.32	525.07
Earnings From Continuing Operations	3,673	3,389	2,448	2,473	1,856	1,474
Net Income	3,673	3,389	2,448	2,473	1,856	1,474
Net Income to Common	3,673	3,389	2,448	2,473	1,856	1,474
Net Income Growth	21.66%	38.44%	-1.01%	33.20%	25.96%	47.29%
Shares Outstanding (Basic)	53	53	53	53	53	53
Shares Outstanding (Diluted)	53	53	53	53	53	53
EPS (Basic)	69.33	63.95	46.20	46.67	35.04	27.82
EPS (Diluted)	69.33	63.95	46.20	46.67	35.04	27.82
EPS Growth	21.66%	38.44%	-1.01%	33.20%	25.96%	47.29%
Free Cash Flow	1,184	4,143	883.21	-1,237	1,430	1,038
Free Cash Flow Per Share	22.34	78.20	16.67	-23.34	26.99	19.59
Dividend Per Share	40.000	40.000	30.000	15.810	14.373	9.800
Dividend Growth	33.33%	33.33%	89.75%	10.00%	46.67%	26.92%
Gross Margin	54.68%	50.82%	47.55%	51.79%	50.20%	49.01%
Operating Margin	21.75%	20.29%	18.77%	20.29%	17.79%	18.11%
Profit Margin	13.80%	13.76%	12.38%	15.63%	14.28%	13.78%
Free Cash Flow Margin	4.45%	16.82%	4.47%	-7.82%	11.00%	9.70%
EBITDA	6,102	5,252	3,908	3,392	2,480	2,066
EBITDA Margin	22.93%	21.32%	19.77%	21.45%	19.08%	19.31%
D&A For EBITDA	314.6	254.82	198.44	182.75	166.87	128.81
EBIT	5,787	4,997	3,710	3,209	2,313	1,937
EBIT Margin	21.75%	20.29%	18.77%	20.29%	17.79%	18.11%
Effective Tax Rate	37.64%	32.67%	27.14%	28.23%	23.78%	26.27%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.